ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

50.54
0.24
(0.48%)
終了 6月17日 5:00AM
50.41
-0.13
( -0.26% )
プレマーケット: 7:22PM

TG Therapeutics Inc (TGTX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
50.41
( -0.26% )
買値
49.61
売値
51.00
出来高
220
0.00 日の範囲 0.00
25.33 52 週間の範囲 50.7999
時価総額
前日終値
50.54
始値
-
最終取引時間
18:15:38
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 2,175,799
発行済株式数
141,723,008
配当利回り
PER
17.25
1 株当たり利益 (EPS)
2.87
歳入
700.35M
純利益
461.9M

TG Therapeutics Inc について

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatm... TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company’s development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Morrisville, United States
設立
1993
TG Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker TGTX. The last closing price for TG Therapeutics was US$50.54. Over the last year, TG Therapeutics shares have traded in a share price range of US$ 25.33 to US$ 50.7999.

TG Therapeutics currently has 141,723,008 shares in issue. The market capitalisation of TG Therapeutics is US$7.14 billion. TG Therapeutics has a price to earnings ratio (PE ratio) of 17.25.

TG Therapeutics (TGTX) のオプションフロー概要

全体の流れ

ブルリッシュ

ネットプレミアム

341k

Calls / Puts

400.00%

買い / 売り

125.00%

OTM / ITM

42.86%

Sweeps比率

0.00%

TGTX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
17.0416.232418722643.3750.799943.0126295302848.53793771CS
410.8427.394490775839.5750.799936.475205472243.09113373CS
1219.8865.116279069830.5350.799930.53205153339.06849556CS
2619.8564.954188481730.5650.799926.76199363134.22820291CS
5215.3543.782087849435.0650.799925.33198323133.41486205CS
15624.9197.686274509825.550.79996.46319469422.74785831CS
26014.0238.527067875836.3950.79993.48312757719.52627134CS

TGTX - Frequently Asked Questions (FAQ)

What is the current TG Therapeutics Inc share price?
The current share price of TG Therapeutics Inc is US$ 50.41
How many TG Therapeutics Inc shares are in issue?
TG Therapeutics Inc has 141,723,008 shares in issue
What is the market cap of TG Therapeutics Inc?
The market capitalisation of TG Therapeutics Inc is USD 7.14B
What is the 1 year trading range for TG Therapeutics Inc share price?
TG Therapeutics Inc has traded in the range of US$ 25.33 to US$ 50.7999 during the past year
What is the PE ratio of TG Therapeutics Inc?
The price to earnings ratio of TG Therapeutics Inc is 17.25
What is the cash to sales ratio of TG Therapeutics Inc?
The cash to sales ratio of TG Therapeutics Inc is 10.02
What is the registered address of TG Therapeutics Inc?
The registered address for TG Therapeutics Inc is 3020 Carrington Mill Blvd., Morrisville, North Carolina, 27560
What is the TG Therapeutics Inc website address?
The website address for TG Therapeutics Inc is www.tgtherapeutics.com
Which industry sector does TG Therapeutics Inc operate in?
TG Therapeutics Inc operates in the Biotechnology & Life Sciences sector

TGTX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

TGTX Discussion

投稿を表示